Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO2 Nanosheet–Aptamer Nanoprobe
Citations Over TimeTop 1% of 2014 papers
Abstract
A novel dual-activatable fluorescence/MRI bimodal platform is designed for tumor cell imaging by using a redoxable manganese dioxide (MnO2) nanosheet-aptamer nanoprobe. The redoxable MnO2 nanosheet acts as a DNA nanocarrier, fluorescence quencher, and intracellular glutathione (GSH)-activated MRI contrast agent. In the absence of target cells, neither fluorescence signaling nor MRI contrast of the nanoprobe is activated. In the presence of target cells, the binding of aptamers to their targets weakens the adsorption of aptamers on the MnO2 nanosheets, causing partial fluorescence recovery, illuminating the target cells, and also facilitating the endocytosis of nanoprobes into target cells. After endocytosis, the reduction of MnO2 nanosheets by GSH further activates the fluorescence signals and generates large amounts of Mn(2+) ions suitable for MRI. This platform should facilitate the development of various dual-activatable fluorescence/MRI bimodalities for use in cells or in vivo.
Related Papers
- → Multicolorful fluorescent-nanoprobe composed of Au nanocluster and carbon dots for colorimetric and fluorescent sensing Hg2+ and Cr6+(2018)98 cited
- → A ratiometric nanoprobe based on silver nanoclusters and carbon dots for the fluorescent detection of biothiols(2018)41 cited
- → A near−infrared fluorescent sensor based on the architecture of low−toxic Ag2S quantum dot and MnO2 nanosheet for sensing glutathione in human serum sample(2020)39 cited
- → A Unique Approach to Development of a Multiratiometric Fluorescent Composite Probe for Multichannel Bioimaging(2019)20 cited
- → A ratiometric fluorescent probe for pH detection based on Ag 2 S quantum dots–carbon dots nanohybrids(2020)15 cited